Here’s Why You Should Retain Syneos Health (SYNH) For Now Posted byZacks Equity Research September 29, 2021 Leave a comment on Here’s Why You Should Retain Syneos Health (SYNH) For Now Investors are optimistic about Syneos Health (SYNH), given the strength in its Clinical Solutions business and notable partnership deals.